Anterix (NASDAQ: ATEX) to eliminate COO role as Gerbrandt exits post reorg

Rhea-AI Filing Summary

Anterix Inc. reported a leadership change, announcing that Chief Operating Officer Ryan Gerbrandt will leave the company effective January 9, 2026. His departure is tied to an internal reorganization in which the Chief Operating Officer position is being eliminated.

Subject to his signing a release of claims in favor of the company, Gerbrandt will receive severance benefits applicable to a Legacy Tier 1 Executive under Anterix’s Executive Severance Plan, as previously described in its 2025 proxy statement. This event reflects a structural change in the executive team rather than a disclosed change in the company’s financial outlook.

Insights

Corporate governance and executive compensation analyst

Anterix removes the COO role as part of an internal reorganization, with standard-plan severance for the departing executive.

Anterix Inc. is eliminating the Chief Operating Officer position and, as a result, COO Ryan Gerbrandt will leave effective January 9, 2026. The company characterizes this as an internal reorganization, which indicates a shift in how senior responsibilities will be allocated, though specific future reporting lines are not described.

Gerbrandt’s severance is tied to his status as a Legacy Tier 1 Executive under the existing Executive Severance Plan, and is contingent on signing a release of claims in favor of the company. Because the benefits follow a pre-disclosed plan summarized in the 2025 proxy, this looks like a structured, pre-defined treatment rather than a bespoke exit package, and the filing does not disclose any direct financial guidance or changes in strategic direction.

FALSE000130449200013044922026-01-072026-01-07

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 7, 2026

Anterix Inc.

(Exact name of registrant as specified in its charter)

Delaware

001-36827

33-0745043

(State or other jurisdiction

(Commission File Number)

(IRS Employer

of incorporation)

Identification No.)

3 Garret Mountain Plaza Suite 401 Woodland Park, NJ						07424
(Address of principal executive offices)						(Zip Code)

(973) 771-0300

Registrant’s telephone number, including area code

Not applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading symbol			Name of Each Exchange on which registered
Common Stock, $0.0001 par value			ATEX			The Nasdaq Stock Market LLC
						(NASDAQ Capital Market)

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 7, 2026, Anterix Inc. (the “Company”) announced that Ryan Gerbrandt, Chief Operating Officer, will be leaving the Company effective as of January 9, 2026 in connection with an internal reorganization pursuant to which the Chief Operating Officer position is being eliminated. Subject to Mr. Gerbrandt signing a release of claims in favor of the Company, Mr. Gerbrandt will receive severance benefits applicable to a Legacy Tier 1 Executive under the Company’s Executive Severance Plan as previously described in the “Severance Arrangements with our NEOs” section of the Company’s definitive proxy statement on Schedule 14A for its 2025 annual meeting of stockholders filed with the Securities and Exchange Commission on June 30, 2025, which information is incorporated by reference herein.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

			Anterix Inc.
Date: January 7, 2026			/s/ Gena L. Ashe
			Gena L. Ashe
			Chief Legal Officer and Corporate Secretary

FAQ

What executive change did Anterix (ATEX) announce in this 8-K?

Anterix Inc. announced that its Chief Operating Officer, Ryan Gerbrandt, will be leaving the company effective January 9, 2026, as part of an internal reorganization that eliminates the COO role.

Why is the Anterix (ATEX) COO leaving the company?

The departure of COO Ryan Gerbrandt is described as being in connection with an internal reorganization under which the Chief Operating Officer position is being eliminated.

Will Anterix (ATEX) continue to have a Chief Operating Officer role?

No. Anterix states that the Chief Operating Officer position is being eliminated as part of the internal reorganization associated with Gerbrandt’s departure.

What severance will the departing Anterix COO receive?

Subject to signing a release of claims in favor of Anterix, Ryan Gerbrandt will receive severance benefits applicable to a Legacy Tier 1 Executive under the company’s Executive Severance Plan, as previously described in its 2025 proxy statement.

Is the Anterix COO’s severance package disclosed in detail here?

The filing states that Gerbrandt’s severance follows the terms for a Legacy Tier 1 Executive under Anterix’s Executive Severance Plan, with details incorporated by reference to the company’s 2025 definitive proxy statement.

Does this Anterix (ATEX) filing mention changes to the company’s strategy or finances?

The disclosure focuses on the executive departure, elimination of the COO role, and related severance, and does not discuss changes to company strategy or financial results.